# Effect of Pioglitazone on Ambulatory Blood Pressure

> **NCT00328393** · PHASE3 · COMPLETED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 2 (actual)

## Conditions studied

- Hypertension
- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00328393
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-03
- **Final completion:** 2011-01
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2012-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00328393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00328393, "Effect of Pioglitazone on Ambulatory Blood Pressure". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00328393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*